IgA Nephropathy trials recruiting in Georgia

All IgA Nephropathy trials nationally

Cities in Georgia

Recruiting trials in Georgia

• A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
  NCT06419205 · Phase: Phase 2 · Ages: 16 Years and older · Sex: All (male and female) · Georgia: Lawrenceville
• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
  NCT06712407 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Augusta, Austell, Lawrenceville
• Study of BHV-1400 in IgA Nephropathy
  NCT07054684 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Georgia: Lawrenceville